Parallax Volatility Advisers, L.P. Charles River Laboratories International, Inc. Transaction History

Parallax Volatility Advisers, L.P.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $493 - $716	3 Added 3.9%	80 $18,000
Q3 2023 Nov 14, 2023	BUY	$194.44 - $217.61 $14,971 - $16,755	77 New	77 $15,000
Q3 2022 Nov 14, 2022	BUY	$182.44 - $250.54 $101,801 - $139,801	558 New	558 $110,000
Q4 2020 Feb 16, 2021	BUY	$222.0 - $252.62 $7.27 Million - $8.27 Million	32,739 Added 13931.49%	32,974 $8.24 Million
Q3 2020 Nov 13, 2020	BUY	$175.56 - $226.45 $41,256 - $53,215	235 New	235 $53,000
Q2 2019 Aug 14, 2019	SELL	$123.4 - $148.55 $364,523 - $438,816	-2,954 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $309,638 - $433,440	2,954 New	2,954 $429,000

694

52.2M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $9.56B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.